RGRX dont forget the 102m deficit here, end of Q1 FDA thumbs up it spikes ...... its a thinly traded stock some KBIO explosive volume runs it to orbit
2017 the fund the heart attack drug the best in class highest I've ever seen at 80% improvement of the heart, no competition, we have a few at 35% improved rate
its a KBIO in the making, 2 wall street guys gave it 4,52 price target , we get more partnership down the road and funding for the heart attack/ heart failure drug..... a 40 dollar a share at 200m A/S
i found JAZZ AT .50 turn into 190 a share in 3 years
i was in one in 1.50 to 2.25 then years later it hit 100 share
my goal is to hit a few nice penny stocks then fund this investment long its one of those you look back years back and hate life
the 500k award they got recently should help some, might be seeing some thin diution along the way, end of Q1 2016. results for phase 3, no cure in korea for the dry eye, the heart attack/ heart failure drug is what I'm eyeing on.